Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 3 13Phase NA 3Phase 4 2Phase 1 2Phase 1/2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 2Hodgkin Disease 2Carcinoma, Non-Small-Cell Lung 1

Interventions

pegylated granulocyte colony-stimulating factor 4entecavir 3Granulocyte Colony-Stimulating Factor 3Cyclophosphamide 3Brentuximab Vedotin 3Aprepitant 3Vinblastine 2Prednisolone 2Doxorubicin 2Dexamethasone 2rasburicase 1prednylidene 1plerixafor 1peginterferon alfa-2b 1pegfilgrastim 1golimumab 1fludarabine phosphate 1fludarabine 1fluarix 1ferrous succinate 1dexamethasone 21-phosphate 1arexvy 1abrysvo 1Zidovudine 1Water 1Watchful Waiting 1Vindesine 1Vincristine 1Valproic Acid 1Urate Oxidase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Lymphoma × Vinblastine × Clear all
NCT06831370 2026-02-23

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Takeda

Phase 4 Recruiting
124 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

NCT01088750 2023-12-13

EuroNetLP1

Martin-Luther-Universität Halle-Wittenberg

Phase 4 Completed
225 enrolled
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡